Ecuador vs Kazakhstan: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Ecuador rank
1st
Kazakhstan rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Kazakhstan
How they compare
Ecuador currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
Across all 15 years both countries report, Kazakhstan has been ahead every year.
Ecuador ranks 1st and Kazakhstan ranks 1st of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5% | 64.0% | 60.5% | Kazakhstan |
| 2010s | 21.7% | 97.1% | 75.4% | Kazakhstan |
| 2020s | 95.8% | 100.0% | 4.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Kazakhstan?
- Ecuador, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Kazakhstan?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Kazakhstan?
- 15 years are reported by both, from 2007 to 2024.
- How do Ecuador and Kazakhstan rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Kazakhstan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.